Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-15

FDA Approved: MYCOPHENOLIC ACID — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved a supplemental application for Accord Healthcare Inc.'s mycophenolic acid, supporting its continued regulatory status as a generic immunosuppressan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mycophenolic acid (mycophenolic acid)

Snippet

SUPPL AP for MYCOPHENOLIC ACID (MYCOPHENOLIC ACID)